One80 introduces GeneBridge reinsurance product for gene therapy
Reinsurance News - Jul 01, 2024
One80 Intermediaries (One80), an insurance broker based in Boston, announced the launch of GeneBridge, an innovative product designed to reduce the financial burden of high-cost gene therapy claims. Matthew Power, President, One80, commented: “With the number of gene and cell therapies expected to d...
Recommended Articles
Posted: Apr 01, 2026
Coface, a provider of credit insurance and risk management solutions, has announced the appointment...
Posted: Apr 01, 2026
Swiss Re has appointed Henock Teklu as its new Group Chief Transformation Officer and Group Chief of...
Posted: Apr 01, 2026
A recent Geneva Association report warns that as cyber incidents grow more frequent, sophisticated,...